0002158173-26-000001.txt : 20261015 0002158173-26-000001.hdr.sgml : 20261015 20261015151110 ACCESSION NUMBER: 0002158173-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261015 DATE AS OF CHANGE: 20261015 EFFECTIVENESS DATE: 20261015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immuno Cancer Biotherapeutics, Inc. CENTRAL INDEX KEY: 0002158173 ORGANIZATION NAME: EIN: 993690478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-601448 FILM NUMBER: 261462911 BUSINESS ADDRESS: STREET 1: 48351 277TH ST CITY: CANTON STATE: SD ZIP: 57013-5507 BUSINESS PHONE: 6053107663 MAIL ADDRESS: STREET 1: 48351 277TH ST CITY: CANTON STATE: SD ZIP: 57013-5507 D 1 primary_doc.xml X0708 D LIVE 0002158173 Immuno Cancer Biotherapeutics, Inc. 48351 277TH ST CANTON SD SOUTH DAKOTA 57013-5507 6053107663 DELAWARE None None Corporation true 2024 James Robl 48351 277TH STREET CANTON SD SOUTH DAKOTA 57013 Executive Officer Director Stephen Collins 921 E. WESTMINSTER LAKE FOREST IL ILLINOIS 60045 Director Biotechnology Decline to Disclose 06b false 2026-10-09 false true SAFE (Simple Agreement for Future Equity) false 0 Indefinite 75000 Indefinite false 3 0 0 0 false Immuno Cancer Biotherapeutics, Inc. James Robl James Robl Executive Chairman 2026-10-15